Management of Stage III Non–Small-Cell Lung Cancer: ASCO Guideline | Zendy

Megan E. Daly | Zendy; Navneet Singh | Zendy; Nofisat Ismaila | Zendy; Mara B. Antonoff | Zendy; Douglas A. Arenberg | Zendy; Jeffrey D. Bradley | Zendy; Elizabeth A. David | Zendy; Frank C. Detterbeck | Zendy; Martin Früh | Zendy; Matthew A. Gubens | Zendy; Amy Moore | Zendy; Sukhmani K. Padda | Zendy; Jyoti D. Patel | Zendy; Tanyanika Phillips | Zendy; Angel Qin | Zendy; Clifford G. Robinson | Zendy; Charles B. Simone | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Management of Stage III Non–Small-Cell Lung Cancer: ASCO Guideline

Author(s) -

Megan E. Daly,

Navneet Singh,

Nofisat Ismaila,

Mara B. Antonoff,

Douglas A. Arenberg,

Jeffrey D. Bradley,

Elizabeth A. David,

Frank C. Detterbeck,

Martin Früh,

Matthew A. Gubens,

Amy Moore,

Sukhmani K. Padda,

Jyoti D. Patel,

Tanyanika Phillips,

Angel Qin,

Clifford G. Robinson,

Charles B. Simone

Publication year - 2021

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.21.02528

Subject(s) - medicine , guideline , lung cancer , stage (stratigraphy) , oncology , randomized controlled trial , systematic review , evidence based medicine , radiation therapy , medline , intensive care medicine , alternative medicine , pathology , paleontology , political science , law , biology

PURPOSE To provide evidence-based recommendations to practicing clinicians on management of patients with stage III non–small-cell lung cancer (NSCLC).METHODS An Expert Panel of medical oncology, thoracic surgery, radiation oncology, pulmonary oncology, community oncology, research methodology, and advocacy experts was convened to conduct a literature search, which included systematic reviews, meta-analyses, and randomized controlled trials published from 1990 through 2021. Outcomes of interest included survival, disease-free or recurrence-free survival, and quality of life. Expert Panel members used available evidence and informal consensus to develop evidence-based guideline recommendations.RESULTS The literature search identified 127 relevant studies to inform the evidence base for this guideline.RECOMMENDATIONS Evidence-based recommendations were developed to address evaluation and staging workup of patients with suspected stage III NSCLC, surgical management, neoadjuvant and adjuvant approaches, and management of patients with unresectable stage III NSCLC. Additional information is available at www.asco.org/thoracic-cancer-guidelines .

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research